| abstract |
The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, to be inhaled by nebulization by a patient (eg, a human). The invention also relates to a process for the preparation of said pharmaceutical composition and its use in the treatment of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) in a subject. |